Angelo Zinellu

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

N/A

0Author DataRank · unranked

Indexed papers

3in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 3 papers. Top paper: “Durvalumab Plus Tremelimumab in Solid Tumors: A Systematic Review”.

Durvalumab Plus Tremelimumab in Solid Tumors: A Systematic Review

Advances in Therapy(2021)10.1007/s12325-021-01796-6

N/A

0.464DataRank · unranked

21 citations

Maria R. De Miglio, Antonio Cossu, Maria Rosaria Muroni, Ciriaco Carru, Angelo Zinellu +2 more

A new general regression-based approach for method comparison studies

Clinical Chemistry and Laboratory Medicine(2008)10.1515/cclm.2008.194

N/A

0.434DataRank · unranked

17 citations

Angelo Zinellu, Gerard Aime Pinna, Luca Deiana, Ciriaco Carru, Salvatore Sotgia

Plasma Humanin and Non-Coding RNAs as Biomarkers of Endothelial Dysfunction in Rheumatoid Arthritis: A Pilot Study

Non-Coding RNA(2025)10.3390/ncrna11010005

N/A

0.228DataRank · unranked

3 citations

Sara Cruciani, Biagio Di Lorenzo, Maria R. De Miglio, Angelo Zinellu, Margherita Maioli +4 more